Sapphire Crossing LLC

General

Total Cases42

Active Cases1

Patents1

CourtsD. Delaware D. New Jersey N.D. California

TypeNPE

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

L5

A

PTAB

L5

E

CAFC

L3

E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
03/08/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	REDACTED VERSION of 329 Letter, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Cucuzzella, Lucinda) (Entered: 03/08/2023)
03/08/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	REDACTED VERSION of 327 Letter, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A- F)(Gaza, Anne) (Entered: 03/08/2023)
03/02/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	SO ORDERED re 337 STIPULATION TO EXTEND TIME for the parties to file public versions of Defendants' Letter to the Court (D.I. 327) and Plaintiffs' Response (D.I. 329) to March 8, 2023. ORDERED by Judge Maryellen Noreika on 3/2/2023. (dlw) (Entered: 03/02/2023)
03/01/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	STIPULATION TO EXTEND TIME for the parties to file public versions of Defendants' Letter to the Court (D.I. 327) and Plaintiffs' Response (D.I. 329) to March 8, 2023 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Cucuzzella, Lucinda) (Entered: 03/01/2023)
02/27/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 02/27/2023)
02/24/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	CONSENT JUDGMENT (between Plaintiffs and MSN Defendants). ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 2/24/2023. (dlw) (Entered: 02/24/2023)
02/24/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	PROPOSED CONSENT JUDGMENT (Between Plaintiffs and MSN Defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/24/2023 (dlw). (Entered: 02/24/2023)
02/24/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	CONSENT JUDGMENT (between Plaintiffs and Apotex Defendants). Party Apotex Corp. and Apotex Inc. terminated. Attorney Kevin M. Nelson; Eve H. Ormerod; Sailesh K. Patel; Joel M. Wallace; Matthew T. Wilkerson; Neal C. Belgam and Helen H. Ji terminated as to these Defendants. Signed by Judge Maryellen Noreika on 2/24/2023. (dlw) (Entered: 02/24/2023)
02/24/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	PROPOSED CONSENT JUDGMENT (Between Plaintiffs and Apotex Defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/24/2023 (dlw). (Entered: 02/24/2023)
02/23/23	Intercept Pharma Inc v. Apotex Inc 1:20-CV-01105 ( D. DE )	ORDER AFTER PRETRIAL CONFERENCE - IT IS HEREBY ORDERED that the Proposed Pretrial Order is ADOPTED as modified by any discussion at the Pretrial Conference as well as the parties' agreements in their February 23, 2023 letter. (See D.I. 328 & 330). Defendants' Letter Regarding Request for Bifurcation of Trial (D.I. 314) is DENIED; Plaintiffs' Motion in Limine No. 1 (D.I. 302, Ex. 14.1) is GRANTED; Plaintiffs' Motion in Limine No. 2 (D.I. 302, Ex. 14.2) is DENIED as moot; Plaintiffs' Motion in Limine No. 3 (D.I. 303, Ex. 14.3) is GRANTED; Defendants' Motion in Limine No. 1 (D.I. 303, Ex. 15.1) is DENIED as moot; and Defendants' Motion in Limine No. 2 (D.I. 303, Ex. 15.2) is DENIED. (See D.I. 328 at 4:5-43:18). SEE ORDER FOR FURTHER AND COMPLETE DETAILS. Signed by Judge Maryellen Noreika on 2/23/2023. (dlw) (Entered: 02/23/2023) ORDER AFTER PRETRIAL CONFERENCE - IT IS HEREBY ORDERED that the Proposed Pretrial Order is ADOPTED as modified by any discussion at the Pretrial Conference as well as the parties' agreements in their February 23, 2023 letter. (See D.I. 328 & 330). Defendants' Letter Regarding Request for Bifurcation of Trial (D.I. 314) is DENIED; Plaintiffs' Motion in Limine No. 1 (D.I. 302, Ex. 14.1) is GRANTED; Plaintiffs' Motion in Limine No. 2 (D.I. 302, Ex. 14.2) is DENIED as moot; Plaintiffs' Motion in Limine No. 3 (D.I. 303, Ex. 14.3) is GRANTED; Defendants' Motion in Limine No. 1 (D.I. 303, Ex. 15.1) is DENIED as moot; and Defendants' Motion in Limine No. 2 (D.I. 303, Ex. 15.2) is DENIED. (See D.I. 328 at 4:5-43:18). SEE ORDER FOR FURTHER AND COMPLETE DETAILS. Signed by Judge Maryellen Noreika on 2/23/2023. (dlw) (Entered: 02/23/2023)